Abstract
Anti-migraine triptan drugs are 5-HTIB/ID receptor agonists which are thought to block the neurotransmitter/neuropeptide release from sensory nerve terminals and directly constrict blood vessel smooth muscles. In the present study, we have investigated the anatomical basis for a possible modulation of glutamate release from trigeminal ganglion neurons by 5-HTIB/ID receptor agonists and by 5-HTIF receptor agonists, using double immunohistochemical staining technique in the rat. The majority of 5-HTIB, 5-HTID or 5-HTIF receptor positive neurons were also glutamate positive, but both 5-HTIB, 5-HTID or 5-HTIF receptor single-labeled and glutamate single-labeled neurons were observed. These results suggest that 5-HTIB/ID/IF receptor agonists may modulate glutamate release, and that one mechanism of their anti-migraine action could be the blockade of glutamate release.
Original language | English |
---|---|
Pages (from-to) | 1589-1591 |
Number of pages | 3 |
Journal | NeuroReport |
Volume | 12 |
Issue number | 8 |
DOIs | |
Publication status | Published - 13 Jun 2001 |
Externally published | Yes |
Keywords
- 5-HT
- Glutamate
- Migraine
- Trigeminal ganglia
ASJC Scopus subject areas
- General Neuroscience